East-West Collaborative Medicine Using Bee-Venom Acupuncture on Whiplash-Associated Disorders
NCT ID: NCT01369238
Last Updated: 2011-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2011-06-30
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using VAS scale
2. To evaluate the efficacy of East-West collaborative medicine using Bee-Venom Acupuncture Therapy on Whiplash-Associated Disorders using NDI, BDI, SF-36, and EQ-5D.
2. Interventions \& Groups
1. group 1: Bee-Venom Acupuncture Therapy
2. group 2: zaltoprofen
3. group 3: Bee-Venom Acupuncture Therapy \& zaltoprofen
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia
NCT01922466
Treatment for Whiplash Injury
NCT04959721
Bee Venom Acupuncture for the Treatment of Frozen Shoulder
NCT01526031
Evaluate the Effect of Dry Needling on the Temporomandibular Joint in Subjects Who Have Suffered a Whiplash as a Result of a Traffic Accident
NCT06023264
The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain
NCT06028308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bee Venom Acupuncture & zaltoprofen
Bee Venom Acupuncture Therapy
1:4000, SC 1cc/day, 2\~3days/wk, for 1 month
zaltoprofen
80mg/Tab, per os 1Tab tid, for 2 months
zaltoprofen
zaltoprofen
80mg/Tab, per os 1Tab tid, for 2 months
Bee Venom Acupuncture
Bee Venom Acupuncture Therapy
1:4000, SC 1cc/day, 2\~3days/wk, for 1 month
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bee Venom Acupuncture Therapy
1:4000, SC 1cc/day, 2\~3days/wk, for 1 month
zaltoprofen
80mg/Tab, per os 1Tab tid, for 2 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have cervicalgia of more than VAS 5
Exclusion Criteria
* spinal operation
* other musculoskeletal pain
* physicological or mental disorders
25 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korean Pharmacoacupuncture Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Korean Pharmacoacupuncture Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seok-Hee Chung
Role: STUDY_CHAIR
Kyung Hee Oriental Medical Center
Jun-Hwan Lee
Role: STUDY_DIRECTOR
Kyung Hee University Hospital at Gangdong
Koh-Woon Kim
Role: PRINCIPAL_INVESTIGATOR
Kyung Hee Oriental Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KOMC 2010-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.